The Association of Gene Polymorphisms With Invasive Bacterial Infections in Neonates and Young Infants
NCT06985160 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2025-05-22
Summary
Invasive bacterial infections (IBIs) are globally significant, with high mortality rates, particularly within the critical 0-3 month age bracket. The first three months of life mark a peak in IBI prevalence, with an estimated 10-20% of febrile presentations in this age group resulting in an IBI diagnosis. Although multiple factors are implicated in this heightened vulnerability, the precise mechanisms driving the differential development of IBIs among similarly situated infants remain unclear. Genetic diversity and susceptibility are increasingly recognized as influential factors. Extensive literature demonstrates a correlation between genetic polymorphisms and susceptibility to invasive bacterial infections.
This study aims to explore the association of gene polymorphisms TLR4 rs2149356 (c.261-468T\>G), LTA rs2229094 (c.37T\>C), and RFP175 rs1585110 (c.246+8853G\>A) with the occurrence of invasive bacterial infections in the population of children aged under 3 months.
We conducted a prospective observational study at a leading tertiary care hospital. The cohort included 100 infants aged 0-3 months diagnosed with IBIs alongside 100 control infants presenting for non-infectious conditions such as trauma, infantile colic, and hyperbilirubinemia. Cases with any symptoms suggesting an infection were excluded from the control group. Invasive bacterial infections categorized in this study included meningitis, pneumonia, sepsis, bacteremia, urinary tract infections, and invasive bacterial gastroenteritis. Diagnostic criteria were stringent: meningitis was confirmed via signs of bacterial infection in cerebrospinal fluid; pneumonia through auscultatory findings and radiographic evidence of pulmonary infiltrates; bacteremia by positive blood cultures; urinary tract infections by significant bacterial cultures from sterile catheterization; and gastroenteritis by the identification of pathogenic organisms in stool cultures. No additional blood was taken from the patients for the study. Instead, blood samples that were collected for tests determined by the physicians due to the patients' condition in the emergency department were retrieved from the laboratory after the requested tests were completed and reused for the study.
Conditions
- Polymorphism, Genetic
- Bacterial Infections
- Infant
Interventions
- OTHER
-
Specific single nucleotide polymorphisms
Next-generation sequencing was performed to analyze the TLR4, LTA, and RFP175 genes, with a focus on specific single nucleotide polymorphisms
Sponsors & Collaborators
-
Ege University
lead OTHER
Principal Investigators
-
Ali Yurtseven, MD · Ege University, School of Medicine Department of Pediatrics, Izmir, Turkey.
Study Design
- Allocation
- NA
- Purpose
- SCREENING
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 1 Day
- Max Age
- 3 Months
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-04-25
- Primary Completion
- 2023-12-20
- Completion
- 2024-03-15
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Severe Group A Streptococcus Infections in Paris, France, 2018-2023
NCT06297122 ·Status: COMPLETED
-
Host RNA Profiles to Detect Infections in Young Infants
NCT04823026 ·Status: COMPLETED
-
Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity
NCT03246230 ·Status: COMPLETED ·Phase: NA
-
Neutrophil CD64 for Early Diagnosis of Nosocomial Infection in Preterm Newborns
NCT01951781 ·Status: UNKNOWN ·Phase: NA
-
Early Antibiotic Therapy and Vaccinations in Preterm Infants
NCT05563753 ·Status: UNKNOWN
-
Paediatric European Group A Streptococcal United Study.
NCT06058117 ·Status: RECRUITING
-
Febrile Infant Diagnostic Assessment and Outcome Study
NCT05259683 ·Status: COMPLETED
-
New Dosages of Inflammatory Markers for the Early Diagnosis of Nosocomial Bacterial Infections of the Newborn
NCT00701948 ·Status: COMPLETED
-
Burden of Invasive Group B Streptococcal Disease in Infants and Resistance Surveillance in China
NCT02812576 ·Status: UNKNOWN
-
Procalcitonin for Predicting Serious Bacterial Infection in Infants Less Than 3 Months
NCT00800488 ·Status: COMPLETED
-
Preterm Immune System Development and Response to Immunization
NCT05266664 ·Status: RECRUITING
-
Immune Health Biomarkers and Fecal Microbiota in Filipino Breastfed Infants
NCT06708559 ·Status: ACTIVE_NOT_RECRUITING
-
TT-CMV Observational Birth Cohort Study
NCT00907686 ·Status: COMPLETED
-
Comparison of the Effectiveness of Two Different Antibiotic Regimens of the Treatment of Pregnant Women With Preterm Rupture of Membranes
NCT04528251 ·Status: UNKNOWN
-
Microbiome, Antibiotics, and Growth Infant Cohort
NCT03001167 ·Status: COMPLETED
-
New Protocol for Febrile Neonate Management
NCT03183531 ·Status: COMPLETED
-
Serosurveillance Study of Maternally Derived Anti-GBS Antibody
NCT04549220 ·Status: ACTIVE_NOT_RECRUITING
-
Dynamic of the Acquisition of Antibiotic Resistance in Integrons in Neonatology Newborns
NCT02434679 ·Status: COMPLETED
-
The Investigation of Methods to Capture Acute Respiratory and Gastrointestinal Infections of Children Aged 1 to 3 Years
NCT02081833 ·Status: COMPLETED
-
Interest of the Presepsin Assay as a Biomarker of Bacterial Infection, in the Management of Newborns and Infants Under 3 Months of Age Admitted for Fever in Pediatric Emergency Service (Presepsin)
NCT04076345 ·Status: TERMINATED
-
Intestinal Microbiota on Allergy, Growth and Development
NCT03785093 ·Status: ACTIVE_NOT_RECRUITING
-
Identification of New Inborn Errors of Immunity
NCT03414528 ·Status: COMPLETED
-
Systematic Screening for Primary Immunodeficiencies in Patients Hospitalized for Severe Infections in Intensive Care.
NCT04356053 ·Status: UNKNOWN
-
Transfusion-Transmitted Cytomegalovirus Prevention in Neonates
NCT00000584 ·Status: COMPLETED ·Phase: PHASE3
-
The Clinical and Molecular Epidemiology of Streptococcus Agalactiae Colonisation on the Kenyan Coast
NCT01757041 ·Status: COMPLETED